Cargando…

Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells

While the incidence of endometrial cancer continues to rise, the therapeutic options remain limited for advanced or recurrent cases, and most cases are resistant to therapy. The anti-tumor effect of many chemotherapeutic drugs and radiotherapy depends on the induction of DNA damage in cancer cells;...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takeuchi, Makoto, Tanikawa, Michihiro, Nagasaka, Kazunori, Oda, Katsutoshi, Kawata, Yoshiko, Oki, Shinya, Agapiti, Chuwa, Sone, Kenbun, Miyagawa, Yuko, Hiraike, Haruko, Wada-Hiraike, Osamu, Kuramoto, Hiroyuki, Ayabe, Takuya, Osuga, Yutaka, Fujii, Tomoyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966633/ https://www.ncbi.nlm.nih.gov/pubmed/31805725 http://dx.doi.org/10.3390/cancers11121913

Ejemplares similares

Effect of murine double‐minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys
por: Kawata, Yoshiko, et al.
Publicado: (2020)

The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells
por: Kojima, Machiko, et al.
Publicado: (2020)

Ulipristal acetate simultaneously provokes antiproliferative and proinflammatory responses in endometrial cancer cells
por: Kanda, Ranka, et al.
Publicado: (2021)

The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation
por: Kojima, Machiko, et al.
Publicado: (2019)

Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer
por: Oki, Shinya, et al.
Publicado: (2017)

Expression of the glucagon-like peptide-1 receptor and its role in regulating autophagy in endometrial cancer
por: Kanda, Ranka, et al.
Publicado: (2018)

Usefulness of biopsy by office hysteroscopy for endometrial cancer: A case report
por: Sone, Kenbun, et al.
Publicado: (2020)

The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-β/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer
por: Fukui, Shiho, et al.
Publicado: (2019)

MED1, a novel binding partner of BRCA1, regulates homologous recombination and R-loop processing
por: Honjoh, Harunori, et al.
Publicado: (2022)

Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells
por: Fukuda, Tomohiko, et al.
Publicado: (2016)

Characterization of a fluorescence imaging probe that exploits metabolic dependency of ovarian clear cell carcinoma
por: Tsuchimochi, Saki, et al.
Publicado: (2023)

Genotype-Dependent Efficacy of a Dual PI3K/mTOR Inhibitor, NVP-BEZ235, and an mTOR Inhibitor, RAD001, in Endometrial Carcinomas
por: Shoji, Keiko, et al.
Publicado: (2012)

Activation of Nrf2/Keap1 pathway by oral Dimethylfumarate administration alleviates oxidative stress and age-associated infertility might be delayed in the mouse ovary
por: Akino, Nana, et al.
Publicado: (2019)

Polycystic Ovarian Morphology may be a Positive Prognostic Factor in Patients with Endometrial Cancer who Achieved Complete Remission after Fertility-Sparing Therapy with Progestin
por: Fukui, Yamato, et al.
Publicado: (2017)

Automated system for diagnosing endometrial cancer by adopting deep-learning technology in hysteroscopy
por: Takahashi, Yu, et al.
Publicado: (2021)

The Histone Methyltransferase SETD8 Regulates the Expression of Tumor Suppressor Genes via H4K20 Methylation and the p53 Signaling Pathway in Endometrial Cancer Cells
por: Kukita, Asako, et al.
Publicado: (2022)

Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells
por: Miyasaka, Aki, et al.
Publicado: (2014)

Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovary
por: Morita, Yoshihiro, et al.
Publicado: (2012)

Cells with stem‐like properties are associated with the development of HPV18‐positive cervical cancer
por: Kusakabe, Misako, et al.
Publicado: (2022)

Synergistic antitumor effects of combination PI3K/mTOR and MEK inhibition (SAR245409 and pimasertib) in mucinous ovarian carcinoma cells by fluorescence resonance energy transfer imaging
por: Inaba, Kanako, et al.
Publicado: (2016)

High-grade endometrial stromal sarcoma with YWHAE-NUTM2B fusion gene abnormality identified after 10 years of recurrent pulmonary metastases: A case report
por: Takahashi, Yuko, et al.
Publicado: (2023)

Interleukin‐17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma
por: Aotsuka, Aeri, et al.
Publicado: (2019)

Measurement of endometrial thickness by transvaginal ultrasonography to predict pathological response to medroxyprogesterone acetate in patients with grade 1 endometrioid adenocarcinoma
por: SATO, MASAKAZU, et al.
Publicado: (2016)

Evolution of a surgical system using deep learning in minimally invasive surgery (Review)
por: Sone, Kenbun, et al.
Publicado: (2023)

Application of organoid culture from HPV18‐positive small cell carcinoma of the uterine cervix for precision medicine
por: Kusakabe, Misako, et al.
Publicado: (2023)

Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas
por: Uehara, Yuriko, et al.
Publicado: (2015)

Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas
por: Uehara, Yuriko, et al.
Publicado: (2015)

Endometrial cancer with concomitant endometriosis is highly associated with ovarian endometrioid carcinoma: a retrospective cohort study
por: Ishizaka, Aya, et al.
Publicado: (2022)

Enhanced antitumor activity of combined lipid bubble ultrasound and anticancer drugs in gynecological cervical cancers
por: Yamaguchi, Kohei, et al.
Publicado: (2021)

Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer
por: Wada, Miku, et al.
Publicado: (2020)

Role of multifunctional transcription factor TFII-I and putative tumour suppressor DBC1 in cell cycle and DNA double strand damage repair
por: Tanikawa, M, et al.
Publicado: (2013)

Antitumor Activity and Induction of TP53-Dependent Apoptosis toward Ovarian Clear Cell Adenocarcinoma by the Dual PI3K/mTOR Inhibitor DS-7423
por: Kashiyama, Tomoko, et al.
Publicado: (2014)

Identification of DBC1 as a transcriptional repressor for BRCA1
por: Hiraike, H, et al.
Publicado: (2010)

Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy
por: Ikeda, Yuji, et al.
Publicado: (2015)

Huge solitary gallstone complicated with liver cirrhosis in a middle-aged woman: case report
por: Chuwa, Agapiti Hipoliti
Publicado: (2023)

Effect of Different Educational Interventions on Knowledge of HPV Vaccination and Cervical Cancer among Young Women: A Preliminary Report
por: Takahashi, Yuko, et al.
Publicado: (2022)

Detection of HPV RNA molecules in stratified mucin-producing intraepithelial lesion (SMILE) with concurrent cervical intraepithelial lesion: a case report
por: Fukui, Shiho, et al.
Publicado: (2019)

An extremely rare case of pituitary functioning gonadotroph microadenoma accompanied by ovarian hyperstimulation syndrome in a woman of reproductive age
por: Wada-Hiraike, Osamu, et al.
Publicado: (2022)

Multifunctional transcription factor TFII-I is an activator of BRCA1 function
por: Tanikawa, M, et al.
Publicado: (2011)

Validation of an on-chip p16(ink4a)/Ki-67 dual immunostaining cervical cytology system using microfluidic device technology
por: Hashimoto, Kei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_da6aona82a0ng19cjsrgmgjt06